A randomized controlled trial of intranasal ketamine in migraine with prolonged aura
Citation Manager Formats
Make Comment
See Comments

Article Information
- Received December 23, 2011
- Accepted October 10, 2012
- First Published January 30, 2013.
Article Versions
- Previous version (January 30, 2013 - 13:03).
- You are viewing the most recent version of this article.
Author Disclosures
- Shazia K. Afridi, MD,
- Nicola J. Giffin, MD,
- Holger Kaube, MD and
- Peter J. Goadsby, MD, PhD
- Shazia K. Afridi, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Nicola J. Giffin, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Holger Kaube, MD and
1) Merck, Sharp & Dohme, Germany, scientific member 2 years
NONE
NONE
NONE
NONE
NONE
1) Merck, Sharp & Dohme, speaker 2 years, 2) Boehringer-Ingelheim Pharma, speaker 2 years, 3) Pfizer Pharma, speaker, 2 years, 4) Boston Scientific, speaker, 2 years, 5) Medtronic, speaker 2 years, 6) St. Jude Medical, speaker, 2 years, 7) Berlin Chemie, Pharma, speaker, 1 year, 8) MD-Horizonte, speaker, 3 years, 9) Gruenental GmbH, speaker, 1 year
NONE
NONE
NONE
1) IV infusion of Aspirin for headache patients outpatient and inpatient 5%, 2 years
1) Boston Scientific, unrestricted educational grant, 1 year, 2) Medtronic, unrestricted educational grant, 2 years, 3) St. Jude Medical, unrestricted educational grant, 1 years
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Peter J. Goadsby, MD, PhD
I have consulted for the following commercial entities, Alder Bio, Allergan, Amgen, ATI, Boehringer-Ingelheim, BMS, Boston Scientific, Colucid, Coherex, DrReddy, Eli-Lilly, Gammacore, GlaxoSmithKline, Impax, J&J, Linde Gases, Lundbeck, MAP Pharmaceuticals, Medtronic, MSD, Neuralieve, Nevrocorp, Pfizer, Zogenix
NONE
Commerical speaker honoraria, Mennarini
Journal Watch Neurology
NONE
Lance JW, Goadsby PJ. Mechanism and Management of Headache. (7th ed.) New York: Elsevier, 2005
NONE
NONE
NONE
NONE
NONE
GSK, Gammacore, MSD, MAP, Amgen
Department of Defence (PR100085P1)
NONE
NONE
NONE
NONE
NONE
NONE
NONE
Legal firms handling patent matters
- From the Headache Group, Department of Neurology, University of California, San Francisco. S.K.A. is currently affiliated with the Department of Neurology, Guy's Hospital, London, UK. N.J.G. is currently affiliated with the Department of Neurology, Royal United Hospital, Bath, UK. H.K. is currently located in Munich, Germany.
- Correspondence to Dr. Goadsby: pgoadsby{at}headache.ucsf.edu
Article usage
Cited By...
Disputes & Debates: Rapid online correspondence
REQUIREMENTS
If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.